Literature DB >> 17360431

Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis.

Tobias Schmelzle1, Arnaud A Mailleux, Michael Overholtzer, Jason S Carroll, Nicole L Solimini, Eric S Lightcap, Ole P Veiby, Joan S Brugge.   

Abstract

The formation of a lumen in three-dimensional mammary epithelial acinar structures in vitro involves selective apoptosis of centrally localized cells that lack matrix attachment. Similarly, apoptosis is induced by forced detachment of mammary epithelial cells from matrix, a process referred to as anoikis. Through microarray analysis, we found that mRNA levels of the proapoptotic BH3-only protein Bmf are up-regulated during both anoikis and acinar morphogenesis. Importantly, down-regulation of Bmf expression by small interfering RNAs is sufficient to prevent anoikis and acinar cell death and promote anchorage-independent growth to a similar extent as down-regulation of another BH3-only protein, Bim, which was previously shown to be required for these processes. Knockdown of the BH3-only proteins Bad or Bid does not suppress anoikis or luminal apoptosis or promote anchorage-independent growth, but protects from other defined apoptotic stimuli, indicating specificity of BH3-only function. Bmf mRNA is significantly up-regulated upon loss of matrix attachment or disruption of the actin cytoskeleton, but not in response to several other stresses. Interestingly, constitutive activation of the Mek/Erk or phosphatidylinositol 3-kinase/Akt pathways suppresses the transcriptional up-regulation of Bmf during anoikis. Thus, Bmf is a central mediator of anoikis in mammary cells and a target of oncogenes that contribute to the progression of glandular epithelial tumors. Finally, Bmf is expressed during involution of the mouse mammary gland, suggesting that Bmf may also critically contribute to developmental processes in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360431      PMCID: PMC1820662          DOI: 10.1073/pnas.0700115104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Clinging to life: cell to matrix adhesion and cell survival.

Authors:  Peter J Reddig; Rudy L Juliano
Journal:  Cancer Metastasis Rev       Date:  2005-09       Impact factor: 9.264

2.  Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis.

Authors:  Y Zhang; M Adachi; R Kawamura; K Imai
Journal:  Cell Death Differ       Date:  2006-01       Impact factor: 15.828

Review 3.  BCL2 family in DNA damage and cell cycle control.

Authors:  S Zinkel; A Gross; E Yang
Journal:  Cell Death Differ       Date:  2006-06-09       Impact factor: 15.828

4.  Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells.

Authors:  Steven J Isakoff; Jeffrey A Engelman; Hanna Y Irie; Ji Luo; Saskia M Brachmann; Rachel V Pearline; Lewis C Cantley; Joan S Brugge
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 5.  Modelling glandular epithelial cancers in three-dimensional cultures.

Authors:  Jayanta Debnath; Joan S Brugge
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

6.  Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.

Authors:  Erika Krasnickas Keeton; Myles Brown
Journal:  Mol Endocrinol       Date:  2005-03-31

Review 7.  Life in the balance: how BH3-only proteins induce apoptosis.

Authors:  Simon N Willis; Jerry M Adams
Journal:  Curr Opin Cell Biol       Date:  2005-10-21       Impact factor: 8.382

8.  Novel role for PDEF in epithelial cell migration and invasion.

Authors:  Ruwanthi N Gunawardane; Dennis C Sgroi; Carolyn N Wrobel; Eugene Koh; George Q Daley; Joan S Brugge
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

9.  Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells.

Authors:  Masatoshi Ohgushi; Shunsuke Kuroki; Hiroshi Fukamachi; Lorraine A O'Reilly; Keisuke Kuida; Andreas Strasser; Shin Yonehara
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

10.  Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition.

Authors:  Hanna Y Irie; Rachel V Pearline; Dorre Grueneberg; Maximilian Hsia; Preethi Ravichandran; Nayantara Kothari; Sridaran Natesan; Joan S Brugge
Journal:  J Cell Biol       Date:  2005-12-19       Impact factor: 10.539

View more
  81 in total

1.  Three-dimensionally specific inhibition of DNA repair-related genes by activated KRAS in colon crypt model.

Authors:  Toshiyuki Tsunoda; Yasuo Takashima; Takahiro Fujimoto; Midori Koyanagi; Yasuhiro Yoshida; Keiko Doi; Yoko Tanaka; Masahide Kuroki; Takehiko Sasazuki; Senji Shirasawa
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.

Authors:  Yongping Shao; Andrew E Aplin
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

3.  A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.

Authors:  Junegoo Lee; Tilahun Jiffar; Michael E Kupferman
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

4.  DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.

Authors:  Nanyue Chen; Seetharaman Balasenthil; Jacquelyn Reuther; Aileen Frayna; Ying Wang; Dawn S Chandler; Lynne V Abruzzo; Asif Rashid; Jaime Rodriguez; Guillermina Lozano; Yu Cao; Erica Lokken; Jinyun Chen; Marsha L Frazier; Aysegul A Sahin; Ignacio I Wistuba; Subrata Sen; Steven T Lott; Ann McNeill Killary
Journal:  Cancer Discov       Date:  2013-07-09       Impact factor: 39.397

5.  Survival of HER2-Positive Breast Cancer Cells: Receptor Signaling to Apoptotic Control Centers.

Authors:  Marc Y Fink; Jerry E Chipuk
Journal:  Genes Cancer       Date:  2013-05

Review 6.  Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma.

Authors:  Sandra J Strauss; Tony Ng; Ariadna Mendoza-Naranjo; Jeremy Whelan; Poul H B Sorensen
Journal:  Oncologist       Date:  2010-05-17

7.  c-Myb Coordinates Survival and the Expression of Genes That Are Critical for the Pre-BCR Checkpoint.

Authors:  Shawn P Fahl; Andrea R Daamen; Rowena B Crittenden; Timothy P Bender
Journal:  J Immunol       Date:  2018-04-13       Impact factor: 5.422

8.  The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment.

Authors:  Rana Elkholi; Konstantinos V Floros; Jerry E Chipuk
Journal:  Genes Cancer       Date:  2011-05

Review 9.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

10.  The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.

Authors:  Kelly A Whelan; Luciana P Schwab; Sergey V Karakashev; Lisa Franchetti; Gregg J Johannes; Tiffany N Seagroves; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.